Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Raises Hospital Reimbursement Rate For Bone Density Scans, But Is It Enough?

Executive Summary

Advocacy groups for diagnostic services to test for osteoporosis scored a big win when the US Centers for Medicare and Medicaid Services agreed to raise Medicare reimbursement rates for DXA bone density scans in the hospital setting this year rather than cutting the rates as initially proposed. However, there is not such good news for doctors providing in-office DXA scans, as they struggle with continuing declining reimbursement rates that cannot offset the costs of the procedures.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel